Author

Rebecca Adams

Observed names: R. Adams, Rebecca M. Adams, Rebecca Adams

Institutions: Guy's Hospital, King's College London

Observed institutions: Guy's Hospital, King's College London, UNSW Sydney, National Institute for Health and Care Research, University of Oxford, Medawar Building for Pathogen Research, Cardiff University, University of Birmingham

ORCID: 0000-0002-8378-9048

Observed ORCID: 0000-0002-8378-9048

OpenAlex ID: A5065649754

Cx3Cr1 and Vascular Adhesion Protein-1-Dependent Recruitment of Cd16+ Monocytes Across Human Liver Sinusoidal Endothelium

2010 · Alexander I. Aspinall, Stuart M. Curbishley, et al. · Hepatology · 98

B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma

2023 · Silvia Crescioli, Isabel Correa, et al. · Nature Communications · 44

Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma

2024 · Shabana Habib, Gabriel Osborn, et al. · Expert Review of Clinical Immunology · 32

Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies

2022 · Rebecca Adams, Gabriel Osborn, et al. · OncoImmunology · 29

Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction

2025 · Gabriel Osborn, Jacobo López-Abente, et al. · Nature Communications · 26

Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma

2024 · Xinyi Chen, Shabana Habib, et al. · Cancers · 22

Macrophages in ovarian cancer and their interactions with monoclonal antibody therapies

2021 · Gabriel Osborn, Chara Stavraka, et al. · Clinical & Experimental Immunology · 21

Chemokine Pathways in Cutaneous Melanoma: Their Modulation by Cancer and Exploitation by the Clinician

2021 · Rebecca Adams, Bernhard Moser, et al. · Cancers · 13

A novel oncostatin M/interleukin‐31 receptor mutation in familial primary localized cutaneous amyloidosis

2019 · R. Adams, C. Colmont, et al. · Clinical and Experimental Dermatology · 9

Impact of IL-27 on hepatocyte antiviral gene expression and function

2016 · Narayan Ramamurthy, Sara Boninsegna, et al. · Wellcome Open Research · 9

An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al. · Cancer Research · 7

Non‐Allergic Urticarial Skin Reactions Associated With MOv18 IgE , a First‐In‐Class IgE Antibody Recognising Folate Receptor Alpha

2025 · Chara Stavraka, Jitesh Chauhan, et al. · Allergy · 7

Fc-mediated immune stimulating, pro-inflammatory and antitumor effects of anti-HER2 IgE against HER2-expressing and trastuzumab-resistant tumors

2025 · Melanie Grandits, Lais C G F Palhares, et al. · Journal for ImmunoTherapy of Cancer · 7

Molecular Signatures and Functional Pathways of Human Monocytes and Macrophages in Allergy: An EAACI AllergoOncology Scoping Review

2025 · Rodolfo Bianchini, Andrea Escolar‐Peña, et al. · Allergy · 4

Data from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Figure 7 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Supplementary Table 2 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Supplementary Figure 2 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Figure 3 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Figure 2 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Figure 5 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Supplementary Figure 1 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Figure 8 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Figure 4 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Figure 6 from An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer

2025 · Alicia M. Chenoweth, Anthony Cheung, et al.

Works count: 36

Citation count: 328

H-index: 9

I10-index: 8